List of Tables
Table 1. Global DPT Series Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global DPT Series Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global DPT Series Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global DPT Series Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global DPT Series Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global DPT Series Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global DPT Series Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market DPT Series Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of DPT Series Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of DPT Series Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of DPT Series Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of DPT Series Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DPT Series Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on DPT Series Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DPT Series Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global DPT Series Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global DPT Series Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global DPT Series Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global DPT Series Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global DPT Series Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global DPT Series Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global DPT Series Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global DPT Series Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America DPT Series Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America DPT Series Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America DPT Series Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America DPT Series Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America DPT Series Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe DPT Series Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe DPT Series Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe DPT Series Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe DPT Series Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe DPT Series Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific DPT Series Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific DPT Series Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific DPT Series Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific DPT Series Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific DPT Series Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America DPT Series Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America DPT Series Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America DPT Series Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America DPT Series Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America DPT Series Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa DPT Series Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa DPT Series Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa DPT Series Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa DPT Series Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa DPT Series Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global DPT Series Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global DPT Series Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global DPT Series Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global DPT Series Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global DPT Series Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global DPT Series Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global DPT Series Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global DPT Series Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global DPT Series Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global DPT Series Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global DPT Series Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global DPT Series Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global DPT Series Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global DPT Series Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global DPT Series Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global DPT Series Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global DPT Series Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global DPT Series Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global DPT Series Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global DPT Series Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi DPT Series Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK DPT Series Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. AJ Vaccines Company Information
Table 81. AJ Vaccines Description and Business Overview
Table 82. AJ Vaccines DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AJ Vaccines DPT Series Vaccine Product
Table 84. AJ Vaccines Recent Developments/Updates
Table 85. Panacea Biotec Company Information
Table 86. Panacea Biotec Description and Business Overview
Table 87. Panacea Biotec DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Panacea Biotec DPT Series Vaccine Product
Table 89. Panacea Biotec Recent Developments/Updates
Table 90. CNBG Company Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. CNBG DPT Series Vaccine Product
Table 94. CNBG Recent Developments/Updates
Table 95. Hualan Biological Vaccine Company Information
Table 96. Hualan Biological Vaccine Description and Business Overview
Table 97. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hualan Biological Vaccine DPT Series Vaccine Product
Table 99. Hualan Biological Vaccine Recent Developments/Updates
Table 100. BioKangtai Company Information
Table 101. BioKangtai Description and Business Overview
Table 102. BioKangtai DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. BioKangtai DPT Series Vaccine Product
Table 104. BioKangtai Recent Developments/Updates
Table 105. Walvax Biotechnology Company Information
Table 106. Walvax Biotechnology Description and Business Overview
Table 107. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Walvax Biotechnology DPT Series Vaccine Product
Table 109. Walvax Biotechnology Recent Developments/Updates
Table 110. CanSino Biologics Company Information
Table 111. CanSino Biologics Description and Business Overview
Table 112. CanSino Biologics DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CanSino Biologics DPT Series Vaccine Product
Table 114. CanSino Biologics Recent Developments/Updates
Table 115. Chongqing Zhifei Biological Products Company Information
Table 116. Chongqing Zhifei Biological Products Description and Business Overview
Table 117. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chongqing Zhifei Biological Products DPT Series Vaccine Product
Table 119. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. DPT Series Vaccine Distributors List
Table 123. DPT Series Vaccine Customers List
Table 124. DPT Series Vaccine Market Trends
Table 125. DPT Series Vaccine Market Drivers
Table 126. DPT Series Vaccine Market Challenges
Table 127. DPT Series Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of DPT Series Vaccine
Figure 2. Global DPT Series Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global DPT Series Vaccine Market Share by Type: 2025 & 2032
Figure 4. Absorbed Diphtheria-Tetanus Combined Vaccine Product Picture
Figure 5. Absorbed Tetanus Vaccine Product Picture
Figure 6. Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Product Picture
Figure 7. DTP-Hib Quadruple Vaccine Product Picture
Figure 8. DTP-IPV-Hib Pentavalent Vaccine Product Picture
Figure 9. Global DPT Series Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global DPT Series Vaccine Market Share by Application: 2025 & 2032
Figure 11. Adults
Figure 12. Children
Figure 13. Global DPT Series Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global DPT Series Vaccine Market Size (US$ Million), 2021–2032
Figure 15. Global DPT Series Vaccine Sales (K Units), 2021–2032
Figure 16. Global DPT Series Vaccine Average Price (US$/Unit), 2021–2032
Figure 17. DPT Series Vaccine Report Years Considered
Figure 18. DPT Series Vaccine Sales Share by Manufacturers in 2025
Figure 19. Global DPT Series Vaccine Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global DPT Series Vaccine Players: Market Share by Revenue in DPT Series Vaccine in 2025
Figure 21. DPT Series Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global DPT Series Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America DPT Series Vaccine Sales Market Share by Country (2021–2032)
Figure 24. North America DPT Series Vaccine Revenue Market Share by Country (2021–2032)
Figure 25. United States DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe DPT Series Vaccine Sales Market Share by Country (2021–2032)
Figure 28. Europe DPT Series Vaccine Revenue Market Share by Country (2021–2032)
Figure 29. Germany DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific DPT Series Vaccine Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific DPT Series Vaccine Revenue Market Share by Region (2021–2032)
Figure 36. China DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America DPT Series Vaccine Sales Market Share by Country (2021–2032)
Figure 44. Latin America DPT Series Vaccine Revenue Market Share by Country (2021–2032)
Figure 45. Mexico DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa DPT Series Vaccine Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa DPT Series Vaccine Revenue Market Share by Country (2021–2032)
Figure 51. Turkey DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE DPT Series Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of DPT Series Vaccine by Type (2021–2032)
Figure 55. Global Revenue Market Share of DPT Series Vaccine by Type (2021–2032)
Figure 56. Global DPT Series Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of DPT Series Vaccine by Application (2021–2032)
Figure 58. Global Revenue Market Share of DPT Series Vaccine by Application (2021–2032)
Figure 59. Global DPT Series Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 60. DPT Series Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
